Application of Pro-angiogenic Biomaterials in Myocardial Infarction.

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Regenerative Medicine

Background:

• Biomaterials offer potential therapeutic strategies for myocardial infarction (MI).
• They provide mechanical support to the ventricular wall and modulate the cardiac microenvironment.
• A key role of biomaterials in MI treatment is promoting angiogenesis, essential for tissue repair.

Purpose of the Study:

• To systematically review the pro-angiogenic mechanisms and functions of various biomaterials.
• To consolidate understanding of how different biomaterials promote angiogenesis in the context of myocardial infarction.

Main Methods:

• Literature review focusing on studies investigating biomaterial-mediated angiogenesis in myocardial infarction.
• Systematic description and analysis of the mechanisms by which diverse biomaterials exert pro-angiogenic effects.
• Categorization of biomaterials based on their pro-angiogenic functions and underlying pathways.

Main Results:

• Biomaterials demonstrate diverse mechanisms for promoting angiogenesis, including growth factor release, cell recruitment, and matrix remodeling.
• Specific biomaterial properties (e.g., composition, structure, degradation rate) influence their angiogenic potential.
• Understanding these mechanisms is crucial for designing effective biomaterial-based therapies for MI.

Conclusions:

• Biomaterials are promising for MI treatment due to their multifaceted roles, particularly in enhancing angiogenesis.
• A comprehensive understanding of the complex pro-angiogenic actions of different biomaterials is needed.
• This review provides a systematic overview to guide future development of advanced biomaterials for cardiac repair.